Back Current Obesity Report, 12/2, 61-74
Analysts Viewpoint regarding GLP-1 Analogues Market GLP-1 analogues market is driven by strong clinical evidence demonstrating benefits to the cardiovascular and metabolic systems, growing healthcare spending, and extended reimbursement plans that further enhance patient access
Novo Nordisk) for the treatment of adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) and moderate to advanced liver fibrosis, marking the treatment as the first and only glucagon-like peptide-1 receptor agonist (GLP-1 RA) approved for this patient population
Moreover, a well-known ferroptosis inducer, erastin, can be loaded into exosomes labeled with folate and delivered to cancer cells that express the folate receptor to generate ROS and glutathione depletion (Yu et al., 2019)
Single GLP-1 receptor activation (Semaglutide) produces more GI effects than dual GIP/GLP-1 activation (Tirzepatide)
10.1093/brain/aww016 73 SpielmanL